Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study

NCT03895502 is registered in ClinicalTrials.gov with Takeshi Morimoto as lead sponsor.

NCT NCT03895502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03895502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study
Lead sponsor
Takeshi Morimoto
Phase
Phase 4
Overall status
Completed
Start date
May 27, 2019
Completion date
August 31, 2023
Enrollment
605 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant, neoplasms, venous thrombosis